
With the holiday season in full swing and 2021 year coming to an end, we have been looking back and reflecting on all that the National Foundation for Infectious Diseases (NFID) has accomplished with the help of our donors and partners. Amid the challenges of the past year, collaboration has certainly made us stronger and thanks to the generous contributions of so many and the dedicated partnership of our supporting organizations, NFID was able to reach millions across the US in the fight against infectious diseases …
As 2021 comes to a close, take a moment to review the powerful impact of NFID activities featured in the NFID FY21 Annual Report and celebrate the exciting achievements we were able to accomplish with your support.
To download a full copy of the Annual Report, visit www.nfid.org/annual-report
Your Support Makes a Difference
The important work of NFID would not be possible without the support of NFID partners, donors, and stakeholders. From all of us at NFID, thank you for your continued support!
We are extremely grateful to those who have already donated to NFID this year. If you have not yet made a contribution, there is still time to join the fight against infectious diseases through an online donation. We look forward to continued collaboration and building on the momentum of our accomplishments in 2022 and beyond.
We wish you all the gift of health this holiday season and throughout the year.
To join the conversation and get the latest NFID updates, follow us on Twitter, like us on Facebook, follow us on Instagram, visit us on LinkedIn, and subscribe to receive future NFID Updates.
Related Posts

Harnessing the Power of Local Data
NFID dashboard aims to empower stakeholders with hyperlocal data to increase US adult respiratory vaccine uptake

The Key to Preventing Cervical Cancer
January is Cervical Cancer Health Month, an important time to raise awareness and empower individuals to protect themselves against this often preventable type of cancer

Closing the Gap in RSV Prevention
NFID Medical Director Robert H. Hopkins, Jr., MD, shares his perspective on the importance of respiratory syncytial virus (RSV) prevention